Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediLedger Project is an industry-led healthcare technology company/network focused on the pharmaceutical supply chain rather than drug development. Launched in 2017 by Chronicled, it uses a blockchain-based network to help pharmaceutical manufacturers, wholesalers, dispensers, and other trading partners coordinate data, automate contracting and chargebacks, and support DSCSA-compliant product verification and traceability. The platform has been used in high-profile FDA-related pilot work on interoperable track-and-trace for U.S. prescription medicines. Its value proposition centers on secure multi-party data exchange, verification of drug identifiers and provenance, and reduction of administrative friction across life sciences commercial operations. MediLedger is therefore best understood as a commercial health-tech infrastructure and supply-chain interoperability platform serving pharma and healthcare stakeholders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediLedger Project.